Brimonidine Tartrate Solution/ Drops
Product Images NDC 68083-626

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 68083-626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimonidine-spl-10ml-carton (Brimonidine Spl 10ml Carton)

The text appears to be a description of an ophthalmic solution containing brimonidine tartrate 0.1%. The solution is manufactured by Gland Pharma Limited in India and contains various inactive ingredients. The usual dosage is one drop three times daily to the affected eye(s). The storage instructions recommend storing the solution at 15°C to 25°C (59°F to 77°F).*

FDA Label Image

Brimonidine-spl-10ml-label (Brimonidine Spl 10ml Label)

FDA Label Image

Brimonidine-spl-15ml-carton (Brimonidine Spl 15ml Carton)

This text is a label for Brimonidine Tartrate Ophthalmic Solution, intended for use in the eyes. The solution contains 0.1% Brimonidine tartrate as the active ingredient and various inactive components like boric acid, calcium chloride, magnesium chloride, and potassium chloride. The solution is recommended to be used three times a day with one drop in each affected eye. The packaging indicates storage instructions and dosage details, as well as the product's registration number.*

FDA Label Image

Brimonidine-spl-15ml-label (Brimonidine Spl 15ml Label)

This is a description of Brimonidine Tartrate Ophthalmic Solution, which is used for eye care. It contains Brimonidine tartrate 0.1% as the active ingredient and a preservative called Stabilized Oxychloro Complex at a concentration of 0.005%. The usual dosage is one drop three times daily to the affected eye(s). The product is sterile and should be stored at 15° to 26°C (50° to 77°F). Manufactured by Clard Pharma Limited, the solution comes in a 15mL bottle.*

FDA Label Image

Brimonidine-spl-5ml-carton (Brimonidine Spl 5ml Carton)

This text appears to be a product label for an ophthalmic solution containing Brimonidine Tartrate. The product is manufactured by Gland Pharma Limited in India. It is intended for eye use only and contains Brimonidine tartrate 0.1% as the active ingredient. The solution also includes several inactive ingredients such as boric acid, calcium chloride, magnesium chloride, potassium chloride, and others. The usual dosage is one drop three times daily to affected eye(s), and it should be stored at 15° to 25°C.*

FDA Label Image

Brimonidine-spl-5ml-label (Brimonidine Spl 5ml Label)

This is a prescription medicine called Brimonidine Tartrate Ophthalmic Solution for use in the eyes. The usual dosage is one drop three times a day in the affected eye(s). It is stored at a temperature between 15°C to 25°C. The bottle is filled to half its capacity and the manufacturer is Gland Pharma Limited based in Hyderabad, India.*

FDA Label Image

Brimonidine-spl-logo (Brimonidine Spl Logo)

FDA Label Image

Brimonidine-spl-structure (Brimonidine Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.